Key facts
- Notable investors include ZhenFund, Fosun Venture Capital Investment, Country Garden Venture Capital, Guangzhou Science City Venture Capital, Beijing Xietong Chuangxin Holding — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for ChromX Health
- ·The full record, as it builds
Funding rounds
No funding rounds for ChromX Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ChromX Health
Developer of an intelligent breath analysis platform designed for accurate disease rapid diagnosis, early screening, disease monitoring and tracking, and chronic disease health management. The company offers micro-electromechanical systems technologies and artificial intelligence algorithms for multi-breath molecule full-spectrum analysis to replace the currently commonly used single-molecule breath detection, thereby enabling patients and doctors to detect and screen multiple diseases with only one breath.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2021
- Employees
- 65
- Website
- chromxhealth.com/
- Ownership
- Privately Held (backing)
ChromX Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ChromX Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ChromX Health in its N-PORT filings yet. We sweep new filings monthly.